“Deucravacitinib in Plaque Psoriasis: Laboratory Parameters Through 4 Years of Treatment in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s419. Accessed June 24, 2025. https://skin.dermsquared.com/skin/article/view/3086.